Oragenics Inc (OGEN.A)

OGEN.A on American Stock Exchange

19 Dec 2014
Price Change (% chg)

$-0.07 (-6.36%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for OGEN.A


Oragenics, Inc. is focused on the discovery, development and commercialization of a range of technologies associated with oral health, antibiotics and other general health benefits. The Company is developing and seeking partners or commercializing four products, including ProBiora3, LPT3-04, SMaRT Replacement Therapy and... (more)
No analyst recommendations are available for OGEN.A.


Beta: 1.26
Market Cap (Mil.): $37.26
Shares Outstanding (Mil.): 36.18
Dividend: --
Yield (%): --


  OGEN.A Industry Sector
P/E (TTM): -- 37.83 38.47
EPS (TTM): -0.22 -- --
ROI: -96.01 18.99 18.25
ROE: -96.01 19.75 19.13
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Sadif Analytics Prime
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks